Biogen to slash price of its Alzheimer drug in half
Drugmaker said it will cut wholesale cost of drug by 50% next month, which translates to $28,200 a year for patient.
Drugmaker said it will cut wholesale cost of drug by 50% next month, which translates to $28,200 a year for patient.